REVIVE

Serial Number 87837399
602

Registration Progress

Application Filed
Mar 16, 2018
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: REVIVE
Previous Owner: Atlantic Medical Products, LLC
Classes: 003

Trademark Image

REVIVE

Basic Information

Serial Number
87837399
Filing Date
March 16, 2018
Abandonment Date
April 22, 2019
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
May 17, 2019
Classes
003

Rights Holder

Atlantic Medical Products, LLC

16
Address
1402 W Swann Ave
Tampa, FL 33606

Ownership History

Atlantic Medical Products, LLC

Original Applicant
16
Tampa, FL

Legal Representation

Attorney
William P. Ramey III

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

15 events
Date Code Type Description Documents
May 17, 2019 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
May 17, 2019 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Feb 19, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 19, 2018 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Oct 19, 2018 GNFR O FINAL REFUSAL E-MAILED Loading...
Oct 19, 2018 CNFR R FINAL REFUSAL WRITTEN Loading...
Sep 22, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 21, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 21, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 3, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 3, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 3, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 27, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 23, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 20, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 003
Cosmetic creams for skin care, namely cosmetic creams formulated for use by cancer patients undergoing radiation treatment to address the issue of Radiation Dermatitis
First Use Anywhere: Jun 9, 2017
First Use in Commerce: Mar 1, 2018

Classification

International Classes
003